Search results
Results from the WOW.Com Content Network
The historical application of biotechnology throughout time is provided below in chronological order.. These discoveries, inventions and modifications are evidence of the application of biotechnology since before the common era and describe notable events in the research, development and regulation of biotechnology.
Also, in 1989 in the USSR, the public environmental concerns made the government decide to close down (or convert to different technologies) all 8 paraffin-fed-yeast plants that the Soviet Ministry of Microbiological Industry had by that time. [citation needed] In the late 1970s, biotechnology offered another possible solution to a societal crisis.
500 BC – Pills were used. They were presumably invented so that measured amounts of a medicinal substance could be delivered to a patient. 510–430 BC – Alcmaeon of Croton scientific anatomic dissections. He studied the optic nerves and the brain, arguing that the brain was the seat of the senses and intelligence.
An 18th-century map of Florida. This is a timeline of the U.S. state of Florida. Pre-European. 15,405–14,146 BC: Page-Ladson site. 9320 BC: Cutler Fossil Site.
The history of biology traces the study of the living world from ancient to modern times. Although the concept of biology as a single coherent field arose in the 19th century, the biological sciences emerged from traditions of medicine and natural history reaching back to Ayurveda, ancient Egyptian medicine and the works of Aristotle, Theophrastus and Galen in the ancient Greco-Roman world.
The device described in the post was invented at the Massachusetts Institute of Technology in the 1990s, not by Bill Gates.
A biologist conducting research in a biotechnology laboratory. Biotechnology is a multidisciplinary field that involves the integration of natural sciences and engineering sciences in order to achieve the application of organisms and parts thereof for products and services. [1] Specialists in the field are known as biotechnologists.
The Phase I trial will enroll 80 adult subjects aged 18 to 64 years. 40 subjects will be assigned to the low-dose group, and 40 subjects will be assigned to the high-dose group.